Mario Alberto Accardi, President of the Orexin Program at Centessa Pharmaceuticals ($CNTA), made nine open market sales of company shares over the past year, totaling $1.4 million. His latest sale occurred on December 9, 2025. These transactions rank 4,134th out of 11,678 insiders by sale value, trailing the average of $8.6 million across about six sales per insider. Accardi recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | Chief Executive Officer | A | Share Option (right to buy) | 273000 | $0.00 | 273,000.0000 | 134,447,836 | 9999.99% | 0.20% |
| Feb. 2, 2026 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | Chief Executive Officer | A | Ordinary Shares | 68000 | $0.00 | 243,886.0000 | 134,447,836 | 38.66% | 0.05% |
| Feb. 1, 2026 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | Chief Executive Officer | F | Ordinary Shares | 2915 | $24.57 | 175,886.0000 | 134,447,836 | 1.63% | 0.00% |
| Dec. 9, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | S | Ordinary Shares | 7432 | $28.70 | 181,369.0000 | 134,447,836 | 3.94% | 0.01% |
| Dec. 9, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | S | Ordinary Shares | 2568 | $29.21 | 178,801.0000 | 134,447,836 | 1.42% | 0.00% |
| Dec. 8, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | M | Ordinary Shares | 5000 | $9.53 | 198,801.0000 | 134,447,836 | 2.58% | 0.00% |
| Dec. 8, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | M | Share Option (right to buy) | 5000 | $0.00 | 6,250.0000 | 134,447,836 | 44.44% | 0.00% |
| Dec. 8, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | S | Ordinary Shares | 10000 | $30.00 | 188,801.0000 | 134,447,836 | 5.03% | 0.01% |
| Nov. 1, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | F | Ordinary Shares | 593 | $24.90 | 193,801.0000 | 134,447,836 | 0.31% | 0.00% |
| Oct. 27, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | S | Ordinary Shares | 8000 | $25.00 | 194,394.0000 | 133,184,349 | 3.95% | 0.01% |
| Oct. 27, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | M | Ordinary Shares | 5000 | $8.01 | 202,394.0000 | 133,184,349 | 2.53% | 0.00% |
| Oct. 27, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | M | Share Option (right to buy) | 5000 | $0.00 | 30,000.0000 | 133,184,349 | 14.29% | 0.00% |
| Sept. 16, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | S | Ordinary Shares | 742 | $22.02 | 197,394.0000 | 133,184,349 | 0.37% | 0.00% |
| Sept. 16, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | S | Ordinary Shares | 7430 | $21.33 | 198,136.0000 | 133,184,349 | 3.61% | 0.01% |
| Sept. 9, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | M | Ordinary Shares | 5000 | $8.01 | 212,566.0000 | 133,184,349 | 2.41% | 0.00% |
| Sept. 9, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | M | Share Option (right to buy) | 5000 | $0.00 | 35,000.0000 | 133,184,349 | 12.50% | 0.00% |
| Sept. 9, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | S | Ordinary Shares | 7000 | $20.00 | 205,566.0000 | 133,184,349 | 3.29% | 0.01% |
| Aug. 1, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | F | Ordinary Shares | 597 | $17.17 | 207,566.0000 | 133,184,349 | 0.29% | 0.00% |
| July 29, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | S | Ordinary Shares | 8322 | $15.23 | 208,163.0000 | 133,184,349 | 3.84% | 0.01% |
| June 24, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | M | Share Option (right to buy) | 15000 | $0.00 | 15,300.0000 | 133,184,349 | 49.50% | 0.01% |
| June 24, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | S | Ordinary Shares | 15000 | $14.00 | 216,485.0000 | 133,184,349 | 6.48% | 0.01% |
| June 24, 2025 | Centessa Pharmaceuticals plc | $CNTA | Accardi Mario Alberto | President, Orexin Program | M | Ordinary Shares | 15000 | $3.85 | 231,485.0000 | 133,184,349 | 6.93% | 0.01% |